These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36982690)

  • 41. Application of CRISPR Cas systems in DNA recorders and writers.
    Sen D; Mukhopadhyay P
    Biosystems; 2023 Mar; 225():104870. PubMed ID: 36842456
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Coevolution between bacterial CRISPR-Cas systems and their bacteriophages.
    Watson BNJ; Steens JA; Staals RHJ; Westra ER; van Houte S
    Cell Host Microbe; 2021 May; 29(5):715-725. PubMed ID: 33984274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diversity of CRISPR-Cas immune systems and molecular machines.
    Barrangou R
    Genome Biol; 2015 Nov; 16():247. PubMed ID: 26549499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CRISPR-based adaptive and heritable immunity in prokaryotes.
    van der Oost J; Jore MM; Westra ER; Lundgren M; Brouns SJ
    Trends Biochem Sci; 2009 Aug; 34(8):401-7. PubMed ID: 19646880
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biology and Applications of CRISPR Systems: Harnessing Nature's Toolbox for Genome Engineering.
    Wright AV; Nuñez JK; Doudna JA
    Cell; 2016 Jan; 164(1-2):29-44. PubMed ID: 26771484
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diversity and dynamics of the CRISPR-Cas systems associated with Bacteroides fragilis in human population.
    Lam TJ; Mortensen K; Ye Y
    BMC Genomics; 2022 Aug; 23(1):573. PubMed ID: 35953824
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-resolution crystal structure of the anti-CRISPR protein AcrIC5.
    Kang YJ; Park HH
    Biochem Biophys Res Commun; 2022 Oct; 625():102-108. PubMed ID: 35952606
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diversity, evolution, and therapeutic applications of small RNAs in prokaryotic and eukaryotic immune systems.
    Cooper EL; Overstreet N
    Phys Life Rev; 2014 Mar; 11(1):113-34. PubMed ID: 24286719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering.
    Zheng Y; Li J; Wang B; Han J; Hao Y; Wang S; Ma X; Yang S; Ma L; Yi L; Peng W
    Front Bioeng Biotechnol; 2020; 8():62. PubMed ID: 32195227
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of a comprehensive dataset of diversity generating retroelements generated by the program DiGReF.
    Schillinger T; Lisfi M; Chi J; Cullum J; Zingler N
    BMC Genomics; 2012 Aug; 13():430. PubMed ID: 22928525
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High viral abundance and low diversity are associated with increased CRISPR-Cas prevalence across microbial ecosystems.
    Meaden S; Biswas A; Arkhipova K; Morales SE; Dutilh BE; Westra ER; Fineran PC
    Curr Biol; 2022 Jan; 32(1):220-227.e5. PubMed ID: 34758284
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity.
    Barrangou R; Marraffini LA
    Mol Cell; 2014 Apr; 54(2):234-44. PubMed ID: 24766887
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CRISPR-Cas systems: role in cellular processes beyond adaptive immunity.
    Devi V; Harjai K; Chhibber S
    Folia Microbiol (Praha); 2022 Dec; 67(6):837-850. PubMed ID: 35854181
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Coupling immunity and programmed cell suicide in prokaryotes: Life-or-death choices.
    Koonin EV; Zhang F
    Bioessays; 2017 Jan; 39(1):1-9. PubMed ID: 27896818
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CRISPR-based adaptive immune systems.
    Terns MP; Terns RM
    Curr Opin Microbiol; 2011 Jun; 14(3):321-7. PubMed ID: 21531607
    [TBL] [Abstract][Full Text] [Related]  

  • 56. To acquire or resist: the complex biological effects of CRISPR-Cas systems.
    Bondy-Denomy J; Davidson AR
    Trends Microbiol; 2014 Apr; 22(4):218-25. PubMed ID: 24582529
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Targeted hypermutation of putative antigen sensors in multicellular bacteria.
    Doré H; Eisenberg AR; Junkins EN; Leventhal GE; Ganesh A; Cordero OX; Paul BG; Valentine DL; O'Malley MA; Wilbanks EG
    Proc Natl Acad Sci U S A; 2024 Feb; 121(9):e2316469121. PubMed ID: 38354254
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CRISPR-Cas systems are widespread accessory elements across bacterial and archaeal plasmids.
    Pinilla-Redondo R; Russel J; Mayo-Muñoz D; Shah SA; Garrett RA; Nesme J; Madsen JS; Fineran PC; Sørensen SJ
    Nucleic Acids Res; 2022 May; 50(8):4315-4328. PubMed ID: 34606604
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clustered regularly interspaced short palindromic repeats (CRISPRs): the hallmark of an ingenious antiviral defense mechanism in prokaryotes.
    Al-Attar S; Westra ER; van der Oost J; Brouns SJ
    Biol Chem; 2011 Apr; 392(4):277-89. PubMed ID: 21294681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Digging into the lesser-known aspects of CRISPR biology.
    Guzmán NM; Esquerra-Ruvira B; Mojica FJM
    Int Microbiol; 2021 Nov; 24(4):473-498. PubMed ID: 34487299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.